Conference abstract · 6 Oct 2025
Conference abstractPublished 13 Jul 2018
A new horizon for pediatric aerosolized medication delivery to infants via high flow nasal cannula and vibrating mesh nebulization
University of Chicago Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The global gold standard for delivering aerosolized medication to infants in respiratory distress has been via the Small Volume Jet Nebulizer (SVJN) with a face mask. The medication most commonly used is albuterol 0.083%. During the procedure, a parent must hold the mask on the babyface, which can make the child combative. Therefore, the standard oxygen treatment is moving from face mask to High Flow Nasal cannula (HFNC) in conjunction with aerosolized beta-agonist treatments. A recent study of aerosol drug distribution using a face mask with TC99 label albuterol demonstrated that < less than 1% of the aerosol drug reached the lung and deposition was even less when the infant was crying or upset. Medication delivery is decreased even more when the patient has a nasal cannula in their nose and a pacifier in their mouth. Children are mostly nasal breathers. In vitro pediatric lung model studies with the combination of HFNC&ANB, estimated aerosol deposition at 18 to 26%, although efficacy is low, it is enough to exert a clinical effect when the treatment process was changed to delivery via HFNC and the vibrating mesh nebulizer (AerogenÃ?® Solo Nebulizer), there was improvement with patient and parent comfort levels. Most children were calm and able to sleep throughout the treatment, keep the pacifiers in and some were able to breastfeed during treatment. The clinical indicator that there was better aerosol medication deposition was that many kids experienced an increased heart rate of 10 to 15% from baseline, although they were not being touched or stimulated. Bedside clinician could see medication aerosol exhalation around the pacifiers. Conclusion: This development has revolutionized aerosolized inhaled medication delivery with the ultra-sonic vibrating mesh nebulizer for infants in respiratory distress. More study is needed in this area.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Sherwin Morgan”
